The Global Biopharmaceutical Glass Packaging Market was valued at USD 9.21 Billion in 2024 and is projected to reach USD 15.72 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period. This robust growth is fueled by the surging demand for biologics, monoclonal antibodies, and vaccines, alongside stringent global regulatory mandates that require superior, inert containment solutions to ensure drug stability and patient safety.

As the biopharmaceutical industry advances toward more complex and sensitive therapeutics, the integrity of primary packaging becomes paramount. In this blog, we profile the Top 10 Companies in the Biopharmaceutical Glass Packaging Industry—a group of specialized glass manufacturers, packaging innovators, and material science pioneers who are defining the standards for drug containment worldwide.

---

🔟 1. SCHOTT AG

Headquarters: Mainz, Germany
Key Offering: FIOLAX® borosilicate glass vials, syringes, cartridges, iQ® platform for digital connectivity

SCHOTT AG is a global leader in specialty glass and glass-ceramics, commanding a significant share of the pharmaceutical glass packaging market. Its FIOLAX® borosilicate glass is the industry standard for vials, syringes, and cartridges, prized for its high chemical resistance and hydrolytic stability. The company’s substantial investments, including a landmark $1 billion expansion announced in 2024 for North American and European capacity, underscore its commitment to meeting the exponential demand for biologics packaging.

Innovation & Expansion Initiatives:

• Pioneering the iQ® platform with digital solutions for track-and-trace and integrity monitoring.

• Massive capacity expansion to produce an additional 30,000 tons of glass tubing annually.

• Investment in advanced coating technologies to reduce delamination and protein adsorption for next-gen biologics.

Download FREE Sample Report:
Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

---

9️⃣ 2. Gerresheimer AG

Headquarters: Düsseldorf, Germany
Key Offering: Gx® Glass (borosilicate), vials, ampoules, cartridges, prefillable syringe systems

Gerresheimer AG is a leading partner to the pharma and healthcare industry, offering a comprehensive portfolio of high-quality glass and plastic packaging solutions. Its Gx® Glass, a proprietary borosilicate formulation, is engineered for superior chemical durability, making it ideal for sensitive injectable drugs, vaccines, and biologics. The company operates a global network of state-of-the-art manufacturing plants, ensuring a resilient and compliant supply chain for critical healthcare products.

Innovation & Expansion Initiatives:

• Strategic focus on high-value packaging for mRNA therapies and cell & gene treatments.

• Expanding production lines for ready-to-use (RTU) sterile vials to reduce drug manufacturers’ validation burdens.

• Sustainable manufacturing programs aimed at reducing carbon footprint and increasing recycled-glass content.

---

8️⃣ 3. Corning Incorporated

Headquarters: Corning, New York, USA
Key Offering: Corning Valor® Glass, pharmaceutical glass vials and cartridges

Corning Incorporated revolutionized the market with its proprietary Valor® Glass, a chemically strengthened glass designed to address the industry’s challenges of breakage, delamination, and particulate generation. This innovation offers dramatically improved mechanical strength and chemical durability, enabling faster filling line speeds and enhanced drug stability. Valor® Glass has been rapidly adopted by major vaccine and biologic producers, positioning Corning as a critical disrupter in the packaging landscape.

Innovation & Expansion Initiatives:

• Exclusive focus on Valor® Glass technology, with multi-year supply agreements with top-tier pharmaceutical companies.

• Continuous R&D to develop next-generation, alkali-free glass compositions for ultra-sensitive drug formulations.

• Strategic partnerships with contract development and manufacturing organizations (CDMOs) to drive adoption.

---

7️⃣ 4. Nipro Corporation

Headquarters: Osaka, Japan
Key Offering: Pharmaceutical glass tubes, vials, ampoules, prefillable syringes, plastic containers

Nipro Corporation is a dominant force in Asia and a significant global player, providing a vast array of medical devices and packaging. Its pharmaceutical glass division excels in producing high-quality borosilicate glass tubing, which is converted into vials, ampoules, and cartridges. Nipro is known for its cost-competitiveness and scalability, having expanded its vial production capacity by over 20% in 2023 to capitalize on the region’s booming vaccine and biosimilars market.

Innovation & Expansion Initiatives:

• Strong focus on serving the high-growth biosimilars and generic injectables markets in Asia-Pacific.

• Integration of glass manufacturing with plastic component production to offer complete containment systems.

• Investment in automation and Industry 4.0 technologies to enhance quality control and production efficiency.

Download FREE Sample Report:
Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

---

6️⃣ 5. West Pharmaceutical Services, Inc.

Headquarters: Exton, Pennsylvania, USA
Key Offering: NovaPure® & Westar® ready-to-use vial components, prefillable syringes (Daikyo Crystal Zenith® polymer syringes, FluroTec® coated plungers)

While West Pharma is renowned for its polymer and hybrid systems, it is a pivotal player in the glass packaging ecosystem through its high-value components and assembly services. The company’s NovaPure® and Westar® offerings include ready-to-use (RTU) glass vial components that are washed, siliconized, and sterilized, streamlining the drug manufacturing process. Their expertise in combining glass barrels with advanced polymer stoppers and plungers creates optimized containment solutions for complex biologics.

Innovation & Expansion Initiatives:

• Leadership in integrated containment systems, combining glass with proprietary polymer and coating technologies.

• Rapid scaling of ready-to-use component capacity to meet demand for outsourced manufacturing solutions.

• Focus on combination products and drug delivery devices that incorporate glass primary packaging.

---

5️⃣ 6. Shandong Pharmaceutical Glass Co., Ltd.

Headquarters: Zibo, Shandong, China
Key Offering: Neutral borosilicate glass tubes, vials, ampoules, injection bottles

As one of China’s largest manufacturers of pharmaceutical glass, Shandong Pharmaceutical Glass (SDPG) is a key supplier for domestic and international markets. The company produces massive volumes of neutral borosilicate glass tubing, which is converted into a wide range of primary packaging. SDPG benefits from vertical integration, controlling production from raw materials to finished vials, allowing for stringent quality control and competitive pricing crucial for high-volume generics and vaccines.

Innovation & Expansion Initiatives:

• Significant capacity upgrades to meet GMP standards required for export to regulated markets like Europe and the US.

• Investment in lightweight, eco-friendly glass vials to reduce material use and carbon footprint.

• Focus on becoming a reliable, high-volume supplier for global contract manufacturers and vaccine producers.

---

4️⃣ 7. Becton, Dickinson and Company (BD)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: BD Hypak™ prefillable glass syringes, BD Neopak™ glass cartridges, BD Effivax™ glass vials

BD is a global medical technology leader whose Pharmaceutical Systems unit is a major provider of prefillable syringes and drug delivery systems. Its BD Hypak™ glass syringe system is a market leader, used for a wide range of vaccines and therapeutics. BD’s strength lies in its end-to-end capabilities, offering not just the glass component but also integrated solutions for filling, assembly, and final packaging, which is critical for aseptic processing and high-speed manufacturing.

Innovation & Expansion Initiatives:

• Expansion of prefillable syringe manufacturing capacity globally to support pandemic preparedness and chronic disease therapies.

• Development of specialized siliconization processes for glass syringes to minimize particulate generation and protein interaction.

• Strategic focus on combination products where the glass syringe is integrated with an autoinjector device.

---

3️⃣ 8. Stevanato Group S.p.A.

Headquarters: Piombino Dese, Italy
Key Offering: Borosilicate glass vials, cartridges, syringes, EZ-fill® ready-to-use solutions, visual inspection systems

Stevanato Group is a rapidly growing global provider of drug containment and delivery solutions. The company offers a comprehensive portfolio of high-quality borosilicate glass primary packaging, complemented by its innovative EZ-fill® platform of ready-to-use solutions that reduce contamination risk. Furthermore, Stevanato’s expertise extends to high-speed assembly, inspection, and packaging machinery, offering pharmaceutical clients a unique, integrated service model from primary packaging to final product assembly.

Innovation & Expansion Initiatives:

• Aggressive global expansion, including new manufacturing plants in the U.S. and China to localize supply chains.

• Investment in advanced, high-speed glass converting lines for vials and cartridges.

• Focus on the high-growth segment of biologics and highly potent active pharmaceutical ingredients (HPAPIs).

---

2️⃣ 9. SGD Pharma

Headquarters: Paris, France
Key Offering: Type I borosilicate glass vials and ampoules, aluminosilicate glass for premium applications

SGD Pharma, a member of the Japanese Nihon Yamamura Glass Co., Ltd. group, specializes in manufacturing molded and tubular glass vials and ampoules for the pharmaceutical industry. The company is renowned for its quality and expertise in Type I borosilicate glass, serving a global clientele. SGD Pharma focuses on high-value, niche applications, including premium packaging for high-concentration biologics and specialty pharmaceuticals that demand the highest levels of chemical inertness.

Innovation & Expansion Initiatives:

• Development of specialized glass types like aluminosilicate for enhanced performance with sensitive drug formulations.

• Expansion of its global footprint with a strong focus on servicing the European and North American biopharma hubs.

• Commitment to eco-design, including light-weighting of vials and initiatives to increase the use of cullet (recycled glass) in production.

---

1️⃣ 10. Ardagh Group S.A. (Pharma Glass Business)

Headquarters: Luxembourg City, Luxembourg
Key Offering: Glass vials, ampoules, and cartridges for pharmaceuticals

Ardagh Group, a global leader in metal and glass packaging, operates a dedicated pharmaceutical glass business that produces essential primary packaging. Its facilities manufacture a range of glass containers, primarily focusing on tubular glass vials and ampoules. Ardagh leverages its immense scale and expertise in glass manufacturing to provide reliable, high-volume supply, particularly supporting the packaging needs for generic injectables and high-volume vaccines in both established and emerging markets.

Innovation & Expansion Initiatives:

• Operational focus on efficiency and supply chain reliability for high-demand pharmaceutical products.

• Investment in sustainability, aligning with the group’s broader commitment to reducing environmental impact through energy-efficient furnaces and recycling.

• Strengthening customer partnerships through consistent quality and a global manufacturing footprint.

Get Full Report Here:
Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Biopharmaceutical Glass Packaging Is High-Performance and Sustainable

The biopharmaceutical glass packaging market is undergoing a profound transformation. While traditional borosilicate glass remains indispensable, the industry is racing to innovate with enhanced materials, smart systems, and sustainable manufacturing to meet the demands of next-generation therapeutics and global environmental goals.

📈 Key Trends Shaping the Market:

• Accelerated adoption of ready-to-use (RTU) and advanced coated glass to streamline manufacturing and enhance drug stability for biologics.

• Strong regulatory pressures and industry commitments driving the shift toward carbon-neutral, lightweight, and recyclable glass packaging solutions.

• Rapid capacity expansion and technological upgrades in the Asia-Pacific region to support local biopharma growth and become a global supply hub.

• Increasing integration of digital technologies, such as unique identifiers and connectivity features, into glass packaging for supply chain integrity and patient safety.

Get Full Report Here:
Global Biopharmaceutical Glass Packaging Market – View in Detailed Research Report

The companies listed above are not only supplying critical packaging—they are enabling the safe, effective, and global delivery of the life-saving medicines that define modern healthcare.